Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2515-2516

  Sanchez V ^a   Delgado, J F ^a   Blasco, T ^a   Dalmau, R ^a   Morales, J M ^a   Escribano, P ^a   Tello, R ^a   Hernandez J ^a   Velazquez T ^a   Sotelo, T ^a   Gomez Sanchez M A ^a   Saenz De La Calzada C ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY;

AZATHIOPRINE; CARDIOMYOPATHY, DILATED; CORONARY DISEASE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES;

EID: 0345493774     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00442-X     Document Type: Conference Paper

References (6)

1. Greenberg A., Thompson M.E., Griffith B.J., et al. Transplantation. 50:1990;589.
2. Transplantation. 61:1996;1029.
3. Taylor D.O., Ensley R.D., Olsen S.L., et al. J Heart Lung Transplant. 13:1994;571.
4. Ensley R.D., Bristow M.R., Olsen S.L., et al. Transplantation. 56:1993;75.
5. Mallinger R, Grimm M, Zuckermann G, et al: J Heart Lung Transplant 17:71, 1998 (abstract).
6. Billingham M.E., Cary N.R.B., Hammond E.M., et al. J Heart Transplant. 9:1990;587.